AVEO Stock Hits New 52-Week Low (AVEO)

NEW YORK ( TheStreet) -- AVEO Pharmaceuticals (Nasdaq: AVEO) hit a new 52-week low Tuesday as it is currently trading at $12.92, below its previous 52-week low of $13 with 446,169 shares traded as of 2:40 p.m. ET. Average volume has been 306,900 shares over the past 30 days.

AVEO has a market cap of $604.4 million and is part of the health care sector and drugs industry. Shares are down 20% year to date as of the close of trading on Monday.

AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The company has a P/E ratio of 11.3, above the average drugs industry P/E ratio of 10 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates AVEO as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. You can view the full AVEO Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home